News About: Pharm. Industry
Cialis launched in UK first over the world.
A new anti-impotence pill developed by E. Lilly jointly with Icos, called "Cialis" (tadalafil) went on sale in 15 European countries including England, New Zealand and Australia, signaling the start of a multi-billion...
Cooperate in earlier settlement of differential pricing in insurance-covered drugs
In response to the request from the Korea Pharmaceutical Association (KPA), the Korea Pharmaceutical Manufacturers Association (KPMA) has recently dispatched an official letter to its members, to this effect:
- Rap...
Industrial attention to overseas drug exhibition less paid.
Most of domestic drug industries have shown less attention to the overseas drug exhibition, which obviously called for the great changes in their interests.
The Korea Pharmaceutical Trade Association (KPTA) invited...
Indian Natco marketed Glivec's copy product
An Indian pharmaceutical maker Natco marketed on January 26 Veenat (imatinib mesylate), an identical substance to Glivec through the market approval from the Indian government. Any pharmaceutical makers can produce co...
Industry skeptical about observance of fair trade code
Although the Korea Pharmaceutical Manufacturers Association (KPMA) and Korea Research-based Pharmaceutical Industry Association (KRPIA) agreed to revise the fair trade code last year after the choppy waters of advance...
Domestic pharmaceutical firms eyeing the items with sales greater than 10 billion won
According to the overall management strategies of major domestic pharmaceutical firms this year, the majority of pharmaceutical firms are concentrating their sales and marketing efforts to cultivate ethicals with more...
Pfizer-Pharmacia merger to be completed by the end of first quarter
Pfizer's Chief Executive Officer Henry McKinnell and European Union antitrust chief Mario Monti said on January 24 that they are making on getting Pifzer's $56 billion purchase of rival drugmaker Pharmacia Corp. appro...
Novartis turns up merger heat on rival Roche
Basel-based Novartis revealed on January 23 that it had spent $2.1 billion (11.4% voting stake) to lift its voting stake in Roche Holding AG to 32.7 percent, following Novartis's 21.3% stake at the end of 2001.
Fin...
Bayer's pharma deal still cloudy
Industry sources said that Bayer AG is likely to secure a partner for its ailing drug unit for at least another three months.
"Bayer AG had identified as many as 15 potential partners around the globe but any deal ...
Competition becomes fierce between new drugs and first-generics
Influenced by the sustained growth of ethical market accelerated by a new system of separating drug dispensing from medical practice and the rapid increasing trend of elderly people, multinational pharmaceutical firms...
